Related Experiment Video
Updated: Jun 19, 2025

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
Synergistic Effects of Melatonin on Radiosensitization in Carbon-ion Radiotherapy
Mengyang Ju1, Kazumasa Minami2,3, Shohei Katsuki3
1Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Melatonin enhances carbon-ion radiotherapy by increasing cancer cell sensitivity and suppressing DNA repair mechanisms. This combination therapy shows potential clinical advantages in treating tumors.
Area of Science:
- Oncology
- Radiation Biology
- Molecular Medicine
Background:
- Melatonin's synergy with photon irradiation is known, but its role in carbon-ion radiotherapy is unclear.
- Understanding melatonin's impact on carbon-ion radiotherapy is crucial for optimizing cancer treatment.
Purpose of the Study:
- To investigate the mechanisms and clinical benefits of combining melatonin with carbon-ion radiotherapy.
- To elucidate how melatonin affects cell-cycle modulation and DNA repair in the context of carbon-ion treatment.
Main Methods:
- Utilized melanoma (B16F10) and osteosarcoma (LM8) cell lines.
- Assessed cell-cycle, DNA repair, and gene expression (RNA sequencing) after melatonin and irradiation.
- Validated findings on LM8 cells.
Main Results:
- Melatonin pre-treatment reduced cancer cell survival after photon and carbon-ion radiation.
- Melatonin inhibited G2/M arrest and DNA double-strand break repair gene expression.
- Observed favorable gene expression changes related to survival and metastasis; LM8 cells showed increased radiosensitivity.
Conclusions:
- Exogenous melatonin enhances carbon-ion radiotherapy's cytotoxicity in vitro.
- Melatonin suppresses DNA double-strand break repair pathways, increasing tumor cell radiosensitivity.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Related Concept Videos
Management of Insomnia
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...